// App-Quantinova.ai

PP.12.09 : MASKED-UNCONTROLLED HYPERTENSION MANAGEMENT BASED ON OFFICE BP OR ON OUT-OF-OFFICE (AMBULATORY) BP MEASUREMENT (MASTER) ( STUDY PROTOCOL )

Researchers

Presenter

  • Parati, G

Principal Investigators

  • Bakris, G

  • Bilo, G

  • Branzi, G

  • Faria, T

  • Mancia, G

  • McManus, R

  • Modesti, P

  • Ochoa, J

  • Omboni, S

  • Pellegrini, D

  • Redon, J

  • Schmieder, R.E

  • Soranna, D

  • Stergiou, G.S

  • Wijnmaalen, P

  • Zambon, A

  • Zanchetti, A

Medical Centers

  • University of Milan, Milan, Italy

  • S.Luca Hospital, IRCCS Istituto Auxologico Italiano, Milan, Italy

  • Department of Clinical and Experimental Sciences. University of Brescia, Brescia, Italy

  • Section of Endocrinology, Diabetes and Metabolism, University of Chicago, Chicago, Illinois, IL, USA

  • Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom

  • Medicina sperimentale e clinica, University of Florence, Florence, Italy

  • Clinical Research Unit, Italian Institute of Telemedicine, Varese, Italy

  • INCLIVA Research Institute, University of Valencia, CIBERObn, ISCIII, Madrid, Spain

  • Department of Nephrology and Hypertension, FAU Erlangen-Nürnberg, Erlangen, Germany

  • Hypertension Center STRIDE-7, University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, GREECE

Locations

  • Italy

  • United States

  • United Kingdom

  • Spain

  • Germany

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • Sex hormone binding globulin

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Double Blind/Blinded

  • Open Label

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A